This spotlight on cell
therapy regulation will aim to provide insight into challenges, trends,
developments and debates in the regulation of cell therapies aimed at
regenerative medicine applications. We will explore topics such as how policies
differ globally, the challenge of steering through the regulatory landscape for
both academic researchers and manufacturers, and the number of unproven cell
therapies being advertised on the market.